Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review) - PubMed (original) (raw)
Review
. 2002 Jul-Aug;9(4):683-8.
Affiliations
- PMID: 12066192
Review
Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review)
Marco van Vulpen et al. Oncol Rep. 2002 Jul-Aug.
Abstract
The brain requires a stable internal environment, which is established by the integrity of the blood-brain barrier (BBB). The efficacy of chemotherapeutics in the treatment of brain malignancies is often hampered by the presence of the BBB. BBB disruption can be performed either by osmotic disruption, bradykinin or irradiation. Radiotherapy with doses of 20 to 30 Gy with fraction size of 2 Gy may be used to increase the permeability of the BBB. These radiation doses by themselves will not give rise to serious side effects or long-term complications. Disruption of the BBB by radiotherapy might have implications in the treatment of primary brain tumors, cerebral metastases, and prophylactic cranial irradiation in small cell lung cancer since irradiation will cause cell kill and may enhance the effect of chemotherapy. We present a review on the effects of irradiation on the BBB and subsequently discuss the potential value for therapeutic applications.
Similar articles
- Effects of fractionated radiation on the brain vasculature in a murine model: blood-brain barrier permeability, astrocyte proliferation, and ultrastructural changes.
Yuan H, Gaber MW, Boyd K, Wilson CM, Kiani MF, Merchant TE. Yuan H, et al. Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):860-6. doi: 10.1016/j.ijrobp.2006.06.043. Int J Radiat Oncol Biol Phys. 2006. PMID: 17011458 - Blood-brain barrier and chemotherapeutic treatment of brain tumors.
de Vries NA, Beijnen JH, Boogerd W, van Tellingen O. de Vries NA, et al. Expert Rev Neurother. 2006 Aug;6(8):1199-209. doi: 10.1586/14737175.6.8.1199. Expert Rev Neurother. 2006. PMID: 16893347 Review. - Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?
Kemper EM, Boogerd W, Thuis I, Beijnen JH, van Tellingen O. Kemper EM, et al. Cancer Treat Rev. 2004 Aug;30(5):415-23. doi: 10.1016/j.ctrv.2004.04.001. Cancer Treat Rev. 2004. PMID: 15245774 Review. - [Cerebral metabolism and permeability of the hemato-encephalic barrier in an experimental model for brain radiotherapy].
Cicciarello R, Russi E, Albiero F, Mesiti M, Torre E, D'Aquino A, Raffaele L, Bertolani S, D'Avella D. Cicciarello R, et al. Radiol Med. 1990 Nov;80(5):709-12. Radiol Med. 1990. PMID: 2267391 Italian. - Real-time monitoring of gadolinium diethylenetriamine penta-acetic acid during osmotic blood-brain barrier disruption using magnetic resonance imaging in normal wistar rats.
Blanchette M, Pellerin M, Tremblay L, Lepage M, Fortin D. Blanchette M, et al. Neurosurgery. 2009 Aug;65(2):344-50; discussion 350-1. doi: 10.1227/01.NEU.0000349762.17256.9E. Neurosurgery. 2009. PMID: 19625914
Cited by
- Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide.
Chacko AM, Li C, Pryma DA, Brem S, Coukos G, Muzykantov V. Chacko AM, et al. Expert Opin Drug Deliv. 2013 Jul;10(7):907-26. doi: 10.1517/17425247.2013.808184. Epub 2013 Jun 11. Expert Opin Drug Deliv. 2013. PMID: 23751126 Free PMC article. Review. - Intracranial Control With Combination BRAF and MEK Inhibitor Therapy in Patients With Metastatic Melanoma.
Hui C, Wu YF, Liu K, Sandhu N, Blomain E, Binkley MS, Gephart MH, Chang SD, Li GH, Reddy SA, Soltys SG, Pollom E. Hui C, et al. Cureus. 2022 Nov 23;14(11):e31838. doi: 10.7759/cureus.31838. eCollection 2022 Nov. Cureus. 2022. PMID: 36579260 Free PMC article. - The Tumor Control According to Radiation Dose of Gamma Knife Radiosurgery for Small and Medium-Sized Brain Metastases from Non-Small Cell Lung Cancer.
Park SJ, Lim SH, Kim YJ, Moon KS, Kim IY, Jung S, Kim SK, Oh IJ, Hong JH, Jung TY. Park SJ, et al. J Korean Neurosurg Soc. 2021 Nov;64(6):983-994. doi: 10.3340/jkns.2021.0165. Epub 2021 Oct 25. J Korean Neurosurg Soc. 2021. PMID: 34689476 Free PMC article. - Tissue concentration of systemically administered antineoplastic agents in human brain tumors.
Pitz MW, Desai A, Grossman SA, Blakeley JO. Pitz MW, et al. J Neurooncol. 2011 Sep;104(3):629-38. doi: 10.1007/s11060-011-0564-y. Epub 2011 Mar 12. J Neurooncol. 2011. PMID: 21400119 Free PMC article. Review. - Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema.
Carlson JA, Nooruddin Z, Rusthoven C, Elias A, Borges VF, Diamond JR, Kavanagh B, Kabos P. Carlson JA, et al. Neuro Oncol. 2014 Jul;16(7):1006-9. doi: 10.1093/neuonc/not329. Neuro Oncol. 2014. PMID: 24497407 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical